Publication highlights

Go inside our research

Explore a selection of research case studies from the past five years.

Read now
A Crick researcher reading a scientific paper on a screen.

Intro

Researchers at the Crick are tackling the big questions about human health and disease, and new findings are published every week.

Our faculty have picked some of the most significant papers published by Crick scientists, all of which are freely available thanks to our open science policy.

Highlights

Kinase profile tests

Identifying signalling networks in MEN2 cancer patients

Researchers at the Crick and the University of York with clinicians from Great Ormond Street and Guy’s and St Thomas’ Hospitals have investigated all the kinase enzymes expressed (the kinome) in children with a disease called Multiple Endocrine Neoplasia Type 2 (MEN2), to identify new therapeutic markers and targets. This autosomal dominant disease leads to several cancers including the development of thyroid cancer and is caused by pathogenic variants in the receptor tyrosine kinase RET. But the development and progression of these tumours are not always predictable, even within families with the same RET pathogenic variant. This study identified MEN2 subtype and RET pathogenic variant-specific alterations in signalling pathways including mTOR, PKA, NF-κB and focal adhesions, each of which were subsequently validated in patient thyroid tissue.

Kinome profiling reveals pathogenic variant specific protein signalling networks in MEN2 children with Medullary Thyroid Cancer

Published in npj Precision Oncology

Published

Red blood cells and white blood cells

Age-related genetic changes in the blood associated with poor cancer prognosis

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have discovered that expansion of mutant blood cells, a phenomenon linked to ageing, can be found in cancerous tumours, and this is associated with worse outcomes for patients. Clonal haematopoiesis of indeterminate potential (CHIP) is a condition where blood stem cells accumulate mutations over time. The researchers found that tumour-infiltrating clonal haematopoiesis, not CHIP alone, was associated with greater risk of relapse and cancer death. Patients with TI-CH had an expansion of myeloid cells which can support tumour progression and support. They also discovered that blood cells with TET2 mutations were more likely to be tumour-infiltrating, and that TET2 mutant myeloid cells remodelled the tumour microenvironment. Finally, they validated their findings in over 49,000 patients, finding that mutations were more common in harder-to-treat cancer types.

Tumor-infiltrating clonal hematopoiesis

Published in New England Journal of Medicine

Published

Blood cells in bone marrow

Beneficial genetic changes observed in regular blood donors

Researchers at the Crick have identified genetic changes in blood stem cells from frequent blood donors that support the production of new, non-cancerous cells. The team at the Crick, in collaboration with scientists from the DKFZ in Heidelberg and the German Red Cross Blood Donation Centre, analysed blood samples taken from over 200 frequent donors - people who had donated blood three times a year over 40 years, more than 120 times in total - and sporadic control donors who had donated blood less than five times in total. Samples from both groups showed a similar level of clonal diversity (of blood cells), but the makeup of the blood cell populations was different. For example, both sample groups contained clones with changes to a gene called DNMT3A, which is known to be mutated in people who develop leukaemia. Interestingly, the changes to this gene observed in frequent donors were not in the areas known to be preleukemic.

Clonal hematopoiesis landscape in frequent blood donors

Published in Blood

Published

stem cells

The importance of matching donor and recipient sex in leukaemia mouse xenotransplantation models

Research from the Crick has highlighted the importance of matching donor and recipient sex when transplanting haematopoietic stem cells from humans into mice for research. The researchers assessed engraftment of leukaemia stem cells from 38 patients with AML and umbilical cord blood stem cells from healthy donors. Initially, it looked like leukaemia cells from male patients engrafted better than female patients, but this effect disappeared once the patient and recipient mouse were the same sex. he female AML cells were much more sensitive to recipient sex than male AML cells, as engraftment proved very challenging when using male mice. In general, male AML cells engrafted better in both male and female mice.

Influence of donor-recipient sex on engraftment of normal and leukemia stem cells in xenotransplantation

Published in HemaSphere

Published

Dendritic cells in pink

Understanding types of conventional dendritic cells in mice

Dendritic cells are a family of white blood cells that plays a key role in starting the immune response to infection and cancer, as well as vaccination. However, it has been unclear just how many members of the family there are, especially as they can sometimes appear under different guises. Painstaking reconstruction of dendritic cell family trees by the Reis e Sousa lab now shows that there are three basic types of conventional dendritic cells in mice. They are called cDC1, cDC2A and cDC2B and develop in the bone marrow from “baby” dendritic cells that already have decided to become one or the other type. These cDC1, cDC2A and cDC2B precursor cells then leave the bone marrow to grow up in all tissues of the body, where they then act as lookouts to sound the alarm upon detecting infection or cancer development. Equivalent cells are also found in humans, arguing that this is a conserved feature of the dendritic cell family across species. The research clarifies the complexity of the dendritic cell system, opening the door for future studies to study the exact functions of cDC1s, cDC2As and cDC2Bs in the immune system.

Distinct ontogenetic lineages dictate cDC2 heterogeneity

Published in Nature Immunology

Published

Thymus

Researchers identify stem cells in the thymus for the first time

Researchers at the Francis Crick Institute and UCL have identified stem cells in the human thymus for the first time. These cells represent a potential new target to understand immune diseases and cancer and how to boost the immune system. The researchers found that these stem cells, named Polykeratin cells, express a variety of genes allowing them to give rise to many cell types not previously considered to have a common origin. They can develop into epithelial as well as muscle and neuroendocrine cells, highlighting the importance of the thymus in hormonal regulation. The researchers isolated Polykeratin stem cells in a dish and were able to show that thymus stem cells can be extensively expanded. They demonstrated that all the complex cells in the thymus epithelium could be produced from a single stem cell, highlighting a remarkable and yet untapped regenerative potential.

Defining the identity and the niches of epithelial stem cells with highly pleiotropic multilineage potency in the human thymus

Published in Developmental Cell

Published

A new mark for targeted leukaemia treatment

Researchers in the Bonnet lab have investigated the role of the protein, CKS1, in leukaemic stem cells and found it is vital to their self-renewal capabilities. Blocking the protein in mice did not harm healthy stem cells and, in fact, provided a protective effect for these healthy stem cells from some of the side-effects of chemotherapy.

CKS1 inhibition depletes leukemic stem cells and protects healthy hematopoietic stem cells in acute myeloid leukemia

Published in Science Translational Medicine

Published

Deep analysis of an uncharacterised human haemopoietic stem cell population

Blood is one of the most highly regenerative tissues, with up to a trillion cells being produced daily in adult human bone marrow. A continuous supply of new blood cells throughout life relies on a rare population of hematopoietic stem cells (HSCs). A study from the Bonnet lab has uncovered a hitherto uncharacterised human HSC population which has high repopulating and self-renewal abilities. The ability to isolate and further characterise these cells opens the way to a better understanding of how human haemopoiesis is regulated in health and disease.

Single cell analyses identify a highly regenerative and homogenous human CD34+ hematopoietic stem cell population

Published in Nature Communications

Published

Bone marrow backup needed to tackle respiratory infections

Researchers in the Reis e Sousa lab have found how the immune system triggers an ‘emergency’ dendritic cell response during infection. Dendritic cells have an important role in the immune system, detecting infectious bacteria, fungi or viruses that have entered the body and alerting T cells which recognise and attack the invader. However, there are few dendritic cells in healthy tissue like the lungs which means that, on infection, their numbers need to be boosted. In their study, the team monitored dendritic cells in mice infected with flu virus and found that, after infection, new dendritic cells are released from the bone marrow in response to a chemokine ‘distress’ signal which directs them to the site of infection.

Recruitment of dendritic cell progenitors to foci of influenza A virus infection sustains immunity

Published in Science Immunology

Published

Bone marrow micro-environment in leukemia

A study led by the Bonnet lab looks at how acute myeloid leukemia cells interact with and alter bone marrow. The team has produced an omics repository of potential biomarkers for different bone marrow cell populations.

Integrated OMICs unveil the bone-marrow microenvironment in human leukemia

Published in Cell Reports

Published

Reconstitution of a functional human thymus by postnatal stromal progenitor cells and natural whole-organ scaffolds

In this paper we define the heterogeneity and the clonogenic potential of human thymus stroma; characterise progenitor cells capable of extensive expansion in vitro, thereby achieving clinically relevant numbers with resilience to long-term storage; and report an epithelial-mesenchymal hybrid phenotype of thymus epithelial cells in vivo and in vitro that affects cell behaviour, a unique feature among any epithelia so far reported. We describe a protocol for organs that lack a main vascular access that allowed us to specify the role of natural ECM in supporting organ morphogenesis ex vivo and in vivo; and reconstitute a functional human thymus long-term in vivo.

View the publication

Published in Nature Communications

Published

Versatile humanized niche model enables study of normal and malignant human hematopoiesis

Immunodeficient mouse models have been instrumental in improving our understanding of human healthy haemopoietic stem cells and their hierarchical organisation as well as of the functional and phenotypic heterogeneity of leukaemic stem cells in acute myeloid leukaemia. However, xenotransplantation models failed at reconstituting the human bone marrow niche which remains of mouse origin. Using a bioengineered scaffold, we developed a new versatile humanised bone marrow niche which supports the engraftment of both normal and leukaemia stem cells in vivo. This 3D scaffold represents a suitable model to study and dissect the human bone marrow composition and test the effect of specific stroma cell types and niche factor functions during both normal human haemopoiesis and leukaemia.

View the publication

Published in Journal of Clinical Investigation

Published

COVID testing

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

This important paper showed very high levels of infection amongst healthcare workers in a local hospital. It has influenced government policy – asymptomatic healthcare workers are to be screened as per our recommendation (announced October 12th).

View the publication

Published in The Lancet

Published